|Bid||0.1350 x 0|
|Ask||0.1400 x 0|
|Day's range||0.1400 - 0.1500|
|52-week range||0.0600 - 0.3350|
|Beta (5Y monthly)||1.20|
|PE ratio (TTM)||N/A|
|Earnings date||02 Mar 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||0.50|
Michael Johnson is the CEO of Rhinomed Limited (ASX:RNO). This analysis aims first to contrast CEO compensation with...
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...